Proquility Private Wealth Partners LLC Sells 1,497 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Proquility Private Wealth Partners LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 55.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,202 shares of the company's stock after selling 1,497 shares during the period. Proquility Private Wealth Partners LLC's holdings in HCA Healthcare were worth $361,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Terra Nova Asset Management LLC raised its holdings in HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company's stock valued at $3,297,000 after acquiring an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company's stock valued at $171,000 after acquiring an additional 29 shares in the last quarter. Waldron Private Wealth LLC raised its holdings in HCA Healthcare by 1.8% in the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company's stock valued at $683,000 after acquiring an additional 29 shares in the last quarter. Brookstone Capital Management raised its holdings in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company's stock worth $1,652,000 after buying an additional 30 shares in the last quarter. Finally, UMB Bank n.a. raised its holdings in shares of HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company's stock worth $529,000 after buying an additional 30 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.3 %

Shares of NYSE:HCA traded up $1.06 during trading on Wednesday, reaching $319.53. 1,422,290 shares of the stock were exchanged, compared to its average volume of 1,437,502. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock has a fifty day moving average of $315.10 and a two-hundred day moving average of $353.07. HCA Healthcare, Inc. has a 1-year low of $278.68 and a 1-year high of $417.14. The firm has a market cap of $80.94 billion, a price-to-earnings ratio of 14.34, a price-to-earnings-growth ratio of 1.06 and a beta of 1.64.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.83%. HCA Healthcare's payout ratio is 11.85%.

Insider Transactions at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company's stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the business's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.70% of the company's stock.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. StockNews.com cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Morgan Stanley lowered their price target on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. Oppenheimer boosted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research report on Monday, October 28th. Cantor Fitzgerald restated an "overweight" rating and set a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.